Alerts will be sent to your verified email
Verify Email
KILITCH
|
Kilitch Drugs(India)
|
Medicamen Biotech
|
Prevest Denpro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.81 % | 8.49 % | 23.02 % |
|
5yr average Equity Multiplier
|
1.42 | 1.47 | 1.16 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 0.58 | 0.69 |
|
5yr Avg Net Profit Margin
|
6.07 % | 10.0 % | 28.95 % |
|
Price to Book
|
2.9 | 2.62 | 6.31 |
|
P/E
|
28.12 | 67.31 | 34.03 |
|
5yr Avg Cash Conversion Cycle
|
-7.56 Days | 13.14 Days | 57.55 Days |
|
Inventory Days
|
17.9 Days | 66.66 Days | 26.01 Days |
|
Days Receivable
|
138.92 Days | 122.66 Days | 50.74 Days |
|
Days Payable
|
193.35 Days | 257.34 Days | 75.73 Days |
|
5yr Average Interest Coverage Ratio
|
5.07 | 10.36 | 75.33 |
|
5yr Avg ROCE
|
8.16 % | 12.12 % | 30.18 % |
|
5yr Avg Operating Profit Margin
|
9.07 % | 16.84 % | 36.73 % |
|
5 yr average Debt to Equity
|
0.14 | 0.14 | 0.02 |
|
5yr CAGR Net Profit
|
77.02 % | -6.51 % | 17.49 % |
|
5yr Average Return on Assets
|
3.38 % | 5.75 % | 19.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.23 % | 43.16 % | 73.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.98 % | -0.44 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kilitch Drugs(India)
|
Medicamen Biotech
|
Prevest Denpro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|